168 related articles for article (PubMed ID: 31259858)
1. Clinical and organizational management of cardiac implantable electronic device replacements: an Italian Survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing).
Palmisano P; Ziacchi M; Belotti G; Rapacciuolo A; Santini L; Stabile G; Zoni Berisso M; De Ponti R; Landolina M; Ricci RP; Boriani G;
J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):531-541. PubMed ID: 31259858
[TBL] [Abstract][Full Text] [Related]
2. Change in the use of remote monitoring of cardiac implantable electronic devices in Italian clinical practice over a 5-year period: results of two surveys promoted by the AIAC (Italian Association of Arrhythmology and Cardiac Pacing).
Palmisano P; Melissano D; Zanotto G; Perego GB; Toselli T; Landolina M; Ricci RP;
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):305-314. PubMed ID: 32073430
[TBL] [Abstract][Full Text] [Related]
3. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
[TBL] [Abstract][Full Text] [Related]
4. Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry.
Valzania C; Gadler F; Boriani G; Rapezzi C; Eriksson MJ
Scand Cardiovasc J; 2020 Aug; 54(4):239-247. PubMed ID: 32054352
[No Abstract] [Full Text] [Related]
5. Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases.
Banks H; Torbica A; Valzania C; Varabyova Y; Prevolnik Rupel V; Taylor RS; Hunger T; Walker S; Boriani G; Fattore G;
Europace; 2018 Apr; 20(4):643-653. PubMed ID: 29016747
[TBL] [Abstract][Full Text] [Related]
6. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.
Clémenty N; Carion PL; Léotoing L; Lamarsalle L; Wilquin-Bequet F; Brown B; Verhees KJP; Fernandes J; Deharo JC
Europace; 2018 Dec; 20(12):1974-1980. PubMed ID: 29672690
[TBL] [Abstract][Full Text] [Related]
7. Standards for device implantation and follow-up: personnel, equipment, and facilities: results of the European Heart Rhythm Association Survey.
Todd D; Bongiorni MG; Hernandez-Madrid A; Dagres N; Sciaraffia E; Blomström-Lundqvist C;
Europace; 2014 Aug; 16(8):1236-9. PubMed ID: 25074974
[TBL] [Abstract][Full Text] [Related]
8. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
[TBL] [Abstract][Full Text] [Related]
9. Temporary transvenous cardiac pacing: a survey on current practice.
Diemberger I; Massaro G; Rossillo A; Chieffo E; Dugo D; Guarracini F; Pellegrino PL; Perna F; Landolina M; De Ponti R; Berisso MZ; Ricci RP; Boriani G;
J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):420-427. PubMed ID: 32332379
[TBL] [Abstract][Full Text] [Related]
10. Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey.
Boveda S; Lenarczyk R; Haugaa K; Fumagalli S; Madrid AH; Defaye P; Broadhurst P; Dagres N
Europace; 2016 Sep; 18(9):1434-9. PubMed ID: 27582309
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
[TBL] [Abstract][Full Text] [Related]
12. Causes and predictors of 30-day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database.
Ahmad S; Munir MB; Sharbaugh MS; Althouse AD; Pasupula DK; Saba S
J Cardiovasc Electrophysiol; 2018 Mar; 29(3):456-462. PubMed ID: 29193418
[TBL] [Abstract][Full Text] [Related]
13. A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association.
Raatikainen MJP; Arnar DO; Merkely B; Nielsen JC; Hindricks G; Heidbuchel H; Camm J
Europace; 2017 Aug; 19(suppl_2):ii1-ii90. PubMed ID: 28903470
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Implantable Electronic Device-Related Infection and Extraction Trends in the U.S.
Sridhar AR; Lavu M; Yarlagadda V; Reddy M; Gunda S; Afzal R; Atkins D; Gopinathanair R; Dawn B; Lakkireddy DR
Pacing Clin Electrophysiol; 2017 Mar; 40(3):286-293. PubMed ID: 28084622
[TBL] [Abstract][Full Text] [Related]
15. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
[TBL] [Abstract][Full Text] [Related]
16. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
Tilz R; Boveda S; Deharo JC; Dobreanu D; Haugaa KH; Dagres N
Europace; 2016 Jun; 18(6):945-9. PubMed ID: 27297231
[TBL] [Abstract][Full Text] [Related]
17. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
[TBL] [Abstract][Full Text] [Related]
18. Making the Most of Cardiac Device Remote Management: Towards an Actionable Care Model.
Diamond J; Varma N; Kramer DB
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009497. PubMed ID: 33657833
[No Abstract] [Full Text] [Related]
19. What costs matter? Rethinking social costs of new device technologies.
Choby AA; Clark AM
Europace; 2013 Nov; 15(11):1538-9. PubMed ID: 23833047
[No Abstract] [Full Text] [Related]
20. Trends and Implications of DF-4 Implantable Cardioverter-Defibrillator Lead Adoption in the United States of America.
Li JZ; Bhonsale A; Estes NAM; Jain SK; Kancharla K; Mezu-Chukwu U; Saba S; Shalaby AA; Voigt AH; Wang NC
Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007134. PubMed ID: 30841723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
